Intellipharmaceutics International Inc. (I):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Intellipharmaceutics International Inc. (I) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140544FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Intellipharmaceutics International Inc. (Intellipharmaceutics) is a pharmaceutical company. The company holds expertise in research, development and manufacture of novel and generic targeted-release and controlled-release oral solid dosage drugs. Its product portfolio includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR and Generic Pristiq. Intellipharmaceutics offers products in the areas of neurology, gastrointestinal tract, cardiovascular, diabetes and pain. The company’s technology portfolio includes IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliShuttle, and IntelliPellets among others. It has partnership with Par Pharmaceutical, Inc. The company was formerly known as Intellipharmaceutics Ltd. Intellipharmaceutics is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc. Key Recent Developments

Dec 02, 2013: Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 27, 2013: Intellipharmaceutics announces at-the-market offering of common shares
Oct 01, 2013: Intellipharmaceutics Announces Third Quarter 2013 Results
Jul 02, 2013: Intellipharmaceutics Announces Second Quarter 2013 Results
Apr 24, 2013: Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference

This comprehensive SWOT profile of Intellipharmaceutics International Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intellipharmaceutics International Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intellipharmaceutics International Inc. – Key Information
Intellipharmaceutics International Inc. – Overview
Intellipharmaceutics International Inc. – Key Employees
Intellipharmaceutics International Inc. – Key Employee Biographies
Intellipharmaceutics International Inc. – Key Operational Heads
Intellipharmaceutics International Inc. – Major Products and Services
Intellipharmaceutics International Inc. – History
Intellipharmaceutics International Inc. – Company Statement
Intellipharmaceutics International Inc. – Locations And Subsidiaries
Intellipharmaceutics International Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intellipharmaceutics International Inc. – Business Description
Intellipharmaceutics International Inc. – Corporate Strategy
Intellipharmaceutics International Inc. – SWOT Analysis
SWOT Analysis – Overview
Intellipharmaceutics International Inc. – Strengths
Intellipharmaceutics International Inc. – Weaknesses
Intellipharmaceutics International Inc. – Opportunities
Intellipharmaceutics International Inc. – Threats
Intellipharmaceutics International Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Intellipharmaceutics International Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intellipharmaceutics International Inc., Key Information
Intellipharmaceutics International Inc., Key Ratios
Intellipharmaceutics International Inc., Share Data
Intellipharmaceutics International Inc., Major Products and Services
Intellipharmaceutics International Inc., History
Intellipharmaceutics International Inc., Key Employees
Intellipharmaceutics International Inc., Key Employee Biographies
Intellipharmaceutics International Inc., Key Operational Heads
Intellipharmaceutics International Inc., Other Locations
Intellipharmaceutics International Inc., Subsidiaries
Intellipharmaceutics International Inc., Key Manufacturing facilities
Intellipharmaceutics International Inc., Key Competitors
Intellipharmaceutics International Inc., SWOT Analysis
Intellipharmaceutics International Inc., Ratios based on current share price
Intellipharmaceutics International Inc., Annual Ratios
Intellipharmaceutics International Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intellipharmaceutics International Inc., Performance Chart
Intellipharmaceutics International Inc., Ratio Charts

★海外企業調査レポート[Intellipharmaceutics International Inc. (I):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • Cellular Biomedicine Group Inc (CBMG):企業財務及び戦略的SWOT分析
    Summary Cellular Biomedicine Group Inc (CBMG) is a biomedicine company that develops stem cell therapies to address patient specific medical conditions. The company’s product portfolio includes clinical treatment protocols for the treatment of knee osteoarthritis, cancer, asthma, chronic obstructive …
  • Rhein Petroleum GmbH:企業のM&A・提携動向(石油・ガス分野)
    Summary Rhein Petroleum GmbH (Rhein Petroleum), a subsidiary of Tulip Oil Holding B.V., is an oil and gas company that explores and produces oil and natural gas. The company explores and produce crude oil in the southern German Oberrheingraben and in the Bavarian Alps. Its licensed areas of Oberrhei …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務分析
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Total S.A. (FP):企業のM&A・提携動向(石油・ガス分野)
    Summary Total S.A. (Total) is an integrated global oil and gas company. It produces, refines and markets oil and manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distribution of petroleum prod …
  • Union Technologies Informatique Group SA (FPG):企業財務及び戦略的SWOT分析
    Summary Union Technologies Informatique Group SA (UTi GROUP) is an information technology company that offers technical and business software solutions. The company’s products include OPTIMA, EDI-ONE, NETT / 400 and DATATRACKER. Its OPTIMA is a software for managing fundraising, monitoring and fundi …
  • Cequence Energy, Ltd. (formerly Sabretooth Energy, Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cequence Energy, Ltd. (formerly …
  • AIA Group Limited:企業の戦略・SWOT・財務分析
    SummaryAIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Carticept Medical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Carticept Medical, Inc. (Carticept) develops and markets therapies for patients with osteoarthritis and cartilage injuries. Its products include ultrasound equipments and navigator delivery system. Carticept’s navigator delivery system is an integrated, computer-controlled, and image-guided …
  • Seaspan Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Seaspan Corporation Mergers and …
  • Bhageria Dye Chem Ltd. (530803):企業の財務及び戦略的SWOT分析
    Summary Bhageria Dye Chem Ltd. (Bhageria Dye Chem) is a chemical product manufacturing company that manufactures intermediates and dyes. The company offers products in categories such as pigments, dye stuffs, agro chemicals, dyes, pharmaceuticals, intermediates, and specialty products. It provides i …
  • Electricity Generating Authority of Thailand:企業のM&A・提携動向(発電分野)
    Summary Electricity Generating Authority of Thailand (EGAT) is a state-owned power utility that generates, procures, transmits, sells and distributes electricity. The authority produces energy from hydro, coal, natural gas, diesel, fuel oil and palm oil, and renewable energy sources. It procures pow …
  • Wabash National Corp.の企業概要及び財務/SWOT分析
    Wabash National Corp. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly …
  • Plastiblends India Limited (PLASTIBLEN):企業財務及び戦略的SWOT分析
    Summary Plastiblends India Limited (Plastiblends) is a chemical company that manufactures and exports masterbatches and additive compounds for the plastic processing industry. The company offers products such as additive masterbatches, conductive compounds, polycolor, polycolor black and white, and …
  • Mapletree Commercial Trust:企業の戦略・SWOT・財務分析
    SummaryMapletree Commercial Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Blackwater Midstream Corp. (BWMS)(石油・ガス分野):企業M&A動向
    Summary Blackwater Midstream Corp. (BMC) is an energy service provider. The company develops and operates agricultural, petroleum and chemical liquid terminal storage facilities. Its liquid terminals are used to store products such as gasoline, distillate, crude oil, bunker fuel, diesel, chemicals, …
  • Jiin Yeeh Ding Enterprise Corp. (8390):企業財務及び戦略的SWOT分析
    Summary Jiin Yeeh Ding Enterprise Corp. (Jiin Yeeh Ding) is a waste treatment company that offers electronic waste treatment services. The company recycles industrial waste for the electronic technology industry. It provides gold, copper, silver, palladium and waste precious metal powder for utiliza …
  • EnPro Industries, Inc. (NPO):企業の財務及び戦略的SWOT分析
    Summary EnPro Industries, Inc. (EnPro) is an industrial product manufacturer that offers engineering services. The company designs, develops, manufactures and markets proprietary engineered industrial equipment. It provides sealing technologies, components and service for reciprocating compressors, …
  • Merrimack Pharmaceuticals, Inc. (MACK)(製薬・医療分野):企業M&A動向
    Summary Merrimack Pharmaceuticals, Inc. (Merrimack) is a biopharmaceutical company. The company discovers, develops and provides therapies for the treatment of autoimmune disease and cancer. Its drug products include MM-121, MM-111, MM-151, MM-398, MM-141 and MM-302. The company collaborates with Sa …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆